Polymorphonuclear neutrophils (PMN) play a key role in innate immunity. Their activation and survival are tightly regulated by microbial products via pattern-recognition receptors such as TLRs, which mediate recruitment of the IRAK complex. We describe a new inherited IRAK-4 deficiency in a child with recurrent pyogenic bacterial infections. Analysis of the IRAK4 gene showed compound heterozygosity with two mutations: a missense mutation in the death domain of the protein (p.Arg12Cys) associated in cis with a predicted benign variant (p.Arg391His) and a splice-site mutation in intron 7 that led to the skipping of exon 7. A nontruncated IRAK-4 protein was detected by western blotting. The patient's functional deficiency of IRAK-4 protein was confirmed by the absence of IRAK-1 phosphorylation after stimulation with all TLR agonists tested. The patient's PMN showed strongly impaired responses (L-selectin and CD11b expression, oxidative burst, cytokine production, cell survival) to TLR agonists which engage TLR1/2, TLR2/6, TLR4, and TLR7/8; in contrast, the patient's PMN responses to CpG-DNA (TLR9) were normal, except for cytokine production. The surprisingly normal effect of CpG-DNA on PMN functions and apoptosis disappeared after pretreatment with PI3K inhibitors. Together, these results suggest the existence of an IRAK-4-independent TLR9-induced transduction pathway leading to PI3K
Introduction
Polymorphonuclear neutrophils (PMN) play a key role in host defense against bacterial and fungal pathogens (1) . They contribute to early innate response by rapidly migrating into inflamed tissues, where their activation triggers microbicidal mechanisms such as release of proteolytic enzymes and antimicrobial peptides, and rapid production of reactive oxygen species (ROS), in the so-called oxidative burst. PMN die spontaneously by apoptosis and are then recognized and phagocytosed by macrophages (2) .
PMN directly recognize microbial products via pattern-recognition receptors such as
TLRs. Human PMN have been reported to express all TLRs except TLR3 (3); TLR5 and TLR7 are weakly expressed (4) . TLRs are members of the IL-1R superfamily, characterized by an intracytoplasmic Toll-IL-1 receptor (TIR) domain which mediates recruitment of the interleukin-1 receptor-associated kinase (IRAK) complex via TIR-containing adapter molecules such as MyD88. During formation of this complex, IRAK-4 is activated, leading to hyperphosphorylation of IRAK-1, which in turn induces the interaction of tumor necrosis factor receptor-associated factor 6 (TRAF6) with the complex. TRAF6 then triggers downstream signalling, and this results in NF-κB activation (5, 6) . In addition, TLR engagement activates stress kinases such as MAP kinases, c-Jun NH 2 -terminal kinase (JNK), and phosphatidylinositol 3,4,5-triphosphate kinase (PI3K) in most cells, including PMN (7, 8) . The PI3K pathway has variously been shown to regulate TLR-mediated inflammatory responses, through negative feedback functions (9, 10) , or to enhance NF-κB nuclear translocation (11, 12) . In particular, it was recently suggested that the PI3K signaling cascade occupies a central role in TLR2-induced activation of PMN (13) .
PMN stimulation through TLRs causes an immediate defensive response, including modulation of adhesion molecule expression (L-selectin shedding and β2-integrin HAL author manuscript inserm-00179394, version 1 4 upregulation), production of an array of antimicrobial molecules (ROS and cytokines) (3, 13) , and inhibition of apoptosis (4) . The major role of the TIR-IRAK signaling pathway in immunity to infections by pyogenic bacteria is illustrated by the recent descriptions of children with inherited IRAK-4 deficiency associated with recurrent infections (14) (15) (16) (17) (18) (19) (20) (21) (22) . The cells of these patients fail to respond to IL-1 and IL-18, and to the stimulation of at least five TLRs (TLR2, TLR3, TLR4, TLR5, TLR9).
Here we describe a case of inherited IRAK-4 deficiency related to new double heterozygous mutations generating a non functional IRAK-4 protein. We show that some PMN functions (adhesion molecule expression, ROS production, survival) which are critical for antimicrobial defenses, occur normally in response to CpG-DNA (TLR9), despite an impaired response to the other TLR agonists, suggesting the existence of a distinct TLR9-induced transduction pathway.
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Materials and Methods

Case report
We investigated a 14-year-old boy with recurrent infections, osteomyelitis and cellulitis. He was born in July 1991 and was the second child of healthy unrelated parents. There was no family history of recurrent or severe infections, autoimmune disease, or lymphoma. His brother and sister were healthy. At age 15 days he developed a severe necrotic infection of his palate, due to Pseudomonas aeruginosa. Despite several surgical procedures he had velopharyngeal insufficiency and recurrent otitis media. Vaccines were normally tolerated.
From the age of 5 years he had severe chronic otitis media, arthritis, and impetigenous infections of the face and limbs, usually after skin trauma. Local and systemic antibiotics were usually necessary to eradicate the infections. At age 9 years he underwent tympanoplasty for tympanic membrane perforation, which was complicated by retroauricular cellulitis due to Staphylococcus aureus, and severe impetigo of the face and hands, leading to graft loss. The procedure failed to close the tympanic perforation. At age 10 years he was hospitalized for cervical adenitis associated with fatigue and weight loss. The CRP was elevated, at 24 mg/ml. The PMN count was reduced at 920/mm 3 IgG=12.08g/l (IgG1=10g/l, IgG2=2.52g/l, IgG3=0.72g/l, IgG4=0.05g/l); IgM=1.38g/l) excepted for a still low number of PMN. The complement system was normal.
PMN migration was normal when tested with the under-agarose method, with and without fMLP (10 -7 M) and activated serum (23) , ruling out leucocyte adhesion deficiency (LAD).
PMN phagocytosis of Staphylococcus epidermidis was normal, as was PMN chemiluminescence after stimulation with PMA (100 ng/ml), ruling out a chronic granulomatous disease.
Reagents
The reagents and sources were as follows:
Ultrapurified LPS from E. coli serotype R515 (LPS) and synthetic macrophage-activating 
Incubation of whole blood with TLR agonists
One-milliliter aliquots of fresh blood, collected on lithium heparinate (10 U/ml), were incubated at 37°C for various times with phosphate-buffered saline (PBS), IL-18 (500 ng/ml), or the following TLR agonists (reported to stimulate PMN functions) (4): LPS (10 ng/ml) (TLR4), MALP-2 (10 ng/ml) (TLR2/6), Pam3CSK4 (500 ng/ml) (TLR1/2), R-848 (10 µg/ml) (TLR7/8), and CpG-DNA (100 µg/ml) (TLR9). These optimal concentrations were determined in preliminary concentration-response experiments (personal data).
In some experiments samples were pretreated with the NF-κB inhibitor SN50 (100 µg/ml) or kinase inhibitors at optimal concentrations previously determined in whole blood (wortmannin, 2500 nM; LY2940002, 25 µM; GF109203X, 5µM; genistein, 100 µM; PD98059, 50 µM; SB203580, 25 µM; rottlerin, 10 µM) (4).
Determination of adhesion molecule expression at the PMN and monocyte surface
Whole-blood samples were either kept on ice or incubated at 37°C for 1 hour with PBS, IL-18 or TLR agonists as described above; TNFα (100 U/ml) was used as control. Samples (100 µl)
were then stained at 4°C for 30 minutes with PE-anti-human CD11b or purified anti-L- with HE (1500 ng/ml) at 37°C and then incubated with PBS, IL-18 or TLR agonists as described above; TNFα (100 U/ml) was used as positive control; samples were then treated with PBS or 10 -6 M fMLP for 5 minutes. Red cells were lysed as described above and white cells were resuspended in 1% paraformaldehyde-PBS.
Measurement of PMN apoptosis
Apoptosis of PMN in whole blood was quantified by using annexin V and 7-AAD (an impermeant nuclear dye) as previously described (4, 25) . Samples were incubated in 24-well tissue cultures plates at 37°C with 5% CO 2 for 8 hours with PBS, IL-18 or TLR agonists as described above; GM-CSF (1000 pg/ml) was used as anti-apoptotic control. Samples (100 µl) and phospho-ERK1/2 contents were studied by staining with PE-conjugated anti-phosphop38MAPK and phospho-ERK1/2 Abs. After one wash, leukocytes were resuspended in 1%
paraformaldehyde-PBS.
Cytokine production by blood cells
Blood PMN were isolated in LPS-free conditions in medium containing 9% Dextran T-500 (Pharmacia, Uppsala, Sweden) and 38% Radioselectan (Schering, Lys-Lez-Lannoy, France); the leukocyte suspension was then centrifuged on Ficoll-Paque medium (Pharmacia). The cell pellet was washed with PBS, and erythrocytes were removed by hypotonic lysis; PMN were further purified by negative selection with pan anti-human HLA class II-coated magnetic beads (Miltenyi Biotec) to deplete B lymphocytes, activated T lymphocytes and monocytes as previously described (27) . Less than 0.5% of cells were positive by nonspecific esterase staining, and flow cytometry showed the absence of CD45 + /CD14 high , CD45 + /CD3 + , and CD45 + /CD19 + cells; this showed that the PMN were highly purified, without contaminating monocytes. In parallel, the mononuclear cell ring obtained after Ficoll-Paque centrifugation was treated with anti-CD14-coated magnetic beads (Miltenyi Biotec) to positively select monocytes.
Whole blood, pure PMN (5x10 6 /ml) or pure monocytes (5x10 5 /ml) were cultured for 18 hours at 37°C with 5% CO 2 in 24-well tissue culture plates (Costar, Cambridge, MA) in RPMI 1640 culture medium (Sigma, St Louis, MO). TLR agonists, IL-1β and IL-18 were added to the culture medium. PMA (100 ng/ml) and PMA (100 ng/ml) + ionomycin (10 -5 M) were used as positive controls. Supernatants were stored at -70°C for no longer than 15 days before assay.
IL-8, IL-6, IL-1β and TNFα were detected simultaneously in supernatants by using the human inflammatory cytokine cytometric bead array (CBA) kit (BD Pharmingen, San Diego, CA). The CBA working range was 20-5000 pg/ml for each cytokine.
Flow cytometry
We used a Becton Dickinson FACScalibur (Immunocytometry Systems, San Jose, CA) with a 15-mW, 488-nm argon laser and a 635-nm diode laser. PMN functions were analysed using CellQuest software. To measure apoptosis in whole blood, PMN were identified on the CD15/SSC dot plot and 2x10 5 events were counted per sample. In other experiments, forward and side scatter were used to identify the PMN population and to gate out other cells and debris; 10 4 events were counted per sample. Plasma cytokine levels were analyzed with CBA software (BD Pharmingen).
Blot analysis of IRAK-4
PMN were isolated and highly purified as described above. Suspensions of 40 x 10 6 PMN/ml in PBS buffer were incubated with PBS or TLR agonists for 5 minutes and treated with 2.7 mM diisopropylfluorophosphate for 20 minutes at 4°C then pelleted at 400 g for 8 minutes at following the manufacturer's instructions.
Genetic analysis
The propositus and his parents underwent genetic analysis with their written informed consent. DNA and RNA were extracted from whole blood with Qiagen extraction kits following the manufacturer's instructions. The IRAK4 coding sequence and intron-exon junctions were sequenced in the patient and his parents (PCR conditions and primers are available on request), using an ABI sequencing kit (Applera, Foster City, CA) and a 3130xl DNA sequencer (Applera). cDNA was analyzed after reverse transcription of the patient's RNA by PCR using sets of primers located in various exons (Ex6F cDNA: CTA CTG AAG AAC TGA AAC AGC AGT TTG A; Ex7F cDNA: GTT TAC ATG CCT AAT GGT TCA 12 TTG C, Ex11R cDNA: CGA CAT TGG CTA GCA CCA GAG TA). Forward primers were 6-FAM-labelled. Allele-specific amplification of cDNA was performed using modified oligonucleotides (the 3' end nucleotide is one LNA molecule from Proligo) (Ex10R LNA_G:
TAT CTA GCA ATA ACT GAG GTT CAC; Ex10R LNA_A: TAT CTA GCA ATA ACT GAG GTT CAT ). Analysis of the fluorescent PCR products was done with a 310 DNA sequencer (Applera).
Statistical analysis
Data are reported as means ± SEM. Comparisons were based on ANOVA and Tukey's posthoc test, using Prism 3.0 software (Graph Pad Software).
Results
IRAK4 mutations
The patient's disease was characterized by recurrent infections due to extracellular pyogenic bacteria. Standard immunological studies gave normal results and major PMN defects (i.e.
chronic granulomatous disease) were ruled out. As inherited IRAK-4 deficiency has been associated with recurrent infections (14-22), we analyzed the IRAK4 gene in our patient.
DNA sequencing revealed three mutations: one missense mutation resulting in the substitution of arginine by cystein at position 12 (c. 34 C>T; p.Arg12Cys), a second missense mutation at position 391 (c. 1170 G>A; p.Arg391His), and an intronic mutation at position + RNA from the patient was further studied to assess the potential consequence of the c.831 +5
G>T mutation. For this purpose, primers were designed in exons 6 and 11 and PCR products from the patient's cDNA were analyzed onto ABI310 (Figure 2A ). The presence of an abnormal band revealed that the intronic mutation resulted in a splice defect leading to the skipping of exon 7 and a predicted stop codon at position 249. Sequencing of the shortened PCR band confirmed the abnormal exon 6-8 junction ( Figure 2B ). The observation of a relative abundance of a shortened mRNA without exon 7 as compared with full-length mRNA (see figure 2 ) argued against marked mRNA nonsense-mediated decay and could thus theoretically lead to the production of a truncated protein ending at position 248
The possibility that residual full-length RNA molecules were produced from the maternal allele was excluded by taking advantage of the patient's heterozygosity for the p.Arg391His variant in exon 10. cDNA from the patient was amplified using LNA modified primers with a C or a T at the 3' end (thus specific for the wild-type allele G, ex10R LNA_G, or for the paternal allele A, ex10R LNA_A, figure 3A ). Maternal mRNA molecules were theoretically specifically amplified using ex10R LNA_G and paternally derived mRNA, using ex10R
LNA_A. The specificity of the LNA primers was confirmed using the ex7F and ex10 LNA primers as shown in figure 3B . PCR amplification was only observed with the ex7F and ex10
LNA_G primers in the control (homozygous for the wild-type allele, c.1170 G/G), whereas PCR amplification was positive in the patient using primers ex7F and ex10 LNA_A and negative using primers ex7F and ex10 LNA_G. These results confirmed that full-length mRNA molecules (containing exon 7) were exclusively produced from the paternal allele.
They were confirmed by using Ex6F -ex10R LNA_G, that amplified only exon 7-truncated mRNA, and full-length mRNA molecules using Ex6F -ex10R LNA_A ( Figure 3B ). Together these data confirmed that full-length mRNA molecules were exclusively produced from the paternal allele and thus carried the [p.Arg12Cys and p.Arg391His] mutations.
Presence of a non functional IRAK-4 protein
As expected, a band corresponding to an IRAK-4 protein of apparently normal molecular weight was detected by western blotting of the patient's PMN; no shortened protein was observed ( Figure 1D ). As the first step of IRAK-4 activity is the phosphorylation of IRAK-1 In controls, pretreatment of whole blood with TNFα, GM-CSF, IL-18 or with the various TLR agonists, followed by stimulation with fMLP, a structural analog of bacterial metabolic products, strongly increased ROS production ( Figure 4C) . A similar increase in ROS production was also observed in the patient's PMN after pretreatment with TNFα or GM-CSF and stimulation with fMLP, ruling out defective priming of the phagocyte oxidative burst (31) . This priming effect on the fMLP-stimulated PMN oxidative burst, which was also observed after treatment with CpG-DNA, was no longer detectable after incubation with the other TLR agonists or IL-18 ( Figure 4C ).
Although the effect of TLR agonists on adhesion molecule expression and ROS production by monocytes is far lower than with PMN, the patient's monocytes showed a pattern of responses similar to that of his PMN, with altered responses to TLR agonists except for CpG-DNA (not shown).
Impaired prolongation of PMN survival by IL-18 and TLR agonists, except for TLR9
As (Table II) .
Impaired cytokine production by PMN and monocytes in response to IL-18, IL-1 and all TLR agonists.
In keeping with previous data on patients with IRAK-4 deficiency (15, 16), we found strongly impaired pro-inflammatory cytokine (IL-8) production in the supernatant of the patient's whole-blood samples cultured with all TLR agonists, including CpG-DNA ( Figure 5A ).
Similar results were observed for IL-6, IL-1β and TNFα production (not shown).
As cytokine production by whole blood cells mainly reflects synthesis by monocytes, the patient's monocytes and PMN were isolated and highly purified in order to analyze the individual response of the two cellular subpopulations to TLR agonists, and especially to CpG-DNA (TLR9). As expected, IL-8 production by control monocytes incubated with TLR agonists was far higher than that of control PMN. Neither monocytes ( Figure 5B ) nor PMN ( Figure 5C ) were able to produce significant amounts of IL-8 in response to LPS (TLR4), MALP-2 (TLR2/6), Pam3CSK4 (TLR1/2) nor R-848 (TLR7/8). IL-8 production by the patient's PMN and monocytes in response to CpG-DNA was also strongly diminished as compared to that of cells from a healthy control.
Finally, the parents' PMN exhibited normal responses (adhesion molecule expression, ROS production, delayed apoptosis, cytokine production) to all TLR agonists (not shown).
Involvement of direct stimulation of the PI3K pathway in the preserved PMN responses to TLR9
CpG-DNA induced normal responses by the patient's PMN in terms of survival, adhesion molecule expression and ROS production, despite the lack of functional IRAK-4. This strongly suggested that an alternative pathway, independent of the classic TLR9/IRAK-4 pathway, was involved in TLR9 signaling. We therefore examined the effects of various kinase inhibitors on L-selectin and CD11b expression at the PMN surface, as well as on PMN apoptosis in whole blood incubated with CpG-DNA. These inhibitors were used at optimal concentrations previously determined in whole blood (4) . P.Arg391His, located in cis of the p.Arg12Cys substitution, was predicted to be benign with two software programs based on structural and amino acid conservation, and had no effect on mRNA splicing. A deleterious effect is thus unlikely, but a synergistic deleterious effect of the two missense mutations could not be excluded. The non function of IRAK-4 protein in our patient was also confirmed by the absence of significant IKK phosphorylation, which results from TLR pathway activation (not shown).
TLR9-induced responses, i.e. adhesion molecule expression, ROS production and survival, were normal in the patient's PMN, while cytokine production was lower than with control PMN. This suggests that different pathways may be involved in these functions; in particular, the IRAK-4 dependent pathway is necessary for TLR9-induced cytokine production, while other functions might use independent pathways. PI3Ks have been reported to enhance nuclear translocation of NF-κB through phosphorylation and activation of IκB-kinase and activation of MAPK, especially in TLR2-stimulated PMN (13); nevertheless, it is not known whether MyD88/IRAK-4 complexes are required for this pathway. We clearly found that PI3K inhibitors (wortmannin and LY2940002) totally suppressed the effect of CpG-DNA on adhesion molecule expression and survival of our patient's PMN. These results suggest that TLR9 may be directly linked to PI3K, while the MyD88/IRAK-4 dependent pathway may be required for PI3K activation through the other TLRs. Such direct PI3K activation has been described for TLR2 in a human monocytic cell line (36) .
The lipid products of PI3K -mainly phosphatidylinositol 3,4,5-triphosphate -induce translocation of Akt/PKB to the plasma membrane, where it is phosphorylated and activated by phosphatidyl-inositol 3,4,5-phosphate-dependent kinase (PDK1) (37) . This pathway has been forwarded as a major mediator downstream of PI3K (38) . Ab at 1/500 dilution overnight. The Western blots were revealed as described in Materials and Methods.
FIGURE 2. Mutation + 5 G>T in intron 7 induces exon 7 skipping
A, PCR amplification products using ex6F cDNA and ex11R cDNA primers and cDNA from a control and the patient were analysed onto ABI310 DNA sequencer. A normal PCR product size (647 pb) and a truncated one (532 pb) was observed in our patient.
B, Sequencing of the shortened band was performed using ex6F cDNA and ex11R cDNA non fluorescent primers. A and B, Adhesion molecule expression at the PMN surface: whole-blood samples were incubated at 37°C for 1 hour with PBS, TNFα (100 U/ml), GM-CSF (1000 pg/ml), IL-18
(500 ng/ml) or with the following TLR agonists: LPS (10 ng/ml) (TLR4), MALP-2 (10 ng/ml) (TLR2/6), Pam3CSK4 (500 ng/ml) (TLR1/2), R-848 (10 µg/ml) (TLR7/8), or CpG-DNA (100 µg/ml) (TLR9). Samples were then stained with PE-anti-CD11b and purified anti-L-selectin antibodies at 4°C for 30 minutes.
Results are expressed as mean fluorescence intensity (MFI).
* Significantly different from sample incubated with PBS (p<0.05).
C, PMN oxidative burst: whole-blood samples were pretreated with HE for 15 minutes at 37°C and then incubated with TNFα, GM-CSF, IL-18 or TLR agonists as described above, IL-8 production was measured by using the human inflammatory cytokine cytometric bead array (CBA) kit.
* Significantly different from the sample incubated with PBS (p<0.05) (n=3, each experiment performed with a different healthy control).
HAL author manuscript inserm-00179394, version 1 FIGURE 7. Effect of CpG-DNA on intracellular ERK1/2 and p38MAPK phosphorylation.
Whole-blood samples were preincubated at 37°C in a water bath with PBS or PI3K inhibitors (wortmannin: 2500 nM; LY2940002: 25 µM) for 15 minutes and then with PBS or CpG-DNA (100 µg/ml) for 10 min. Phospho-p38MAPK and phospho-ERK1/2 contents were then measured by flow cytometry on methanol-permeabilized cells as described in Materials and
Methods.
Results are expressed as the mean fluorescence intensity (MFI). Values obtained with an irrelevant Ab of the same isotype were subtracted.
Values are means ± SEM (n=3, each experiment was performed with a different healthy control).
* Significantly different from samples incubated with PBS alone (p<0.05). 
